ALK Digital Pathology Outcome Predition, Multi Institutional, Restrospective Study

Clinical trial NCT06846736 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT06846736
Sponsor: Sheba Medical Center
Status: ENROLLING_BY_INVITATION
Study type: OBSERVATIONAL

Alk-positive Non-Small Cell Lung Cancer ALK-inhibitor Treated

Start date: 2023-08-13
Primary completion: 2027-12-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.